Journal of Gastrointestinal Oncology

Papers
(The median citation count of Journal of Gastrointestinal Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The combination of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), interventional hepatoma therapy, targeted therapy, and immunotherapy: a case series of a novel A34
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study31
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report26
The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma26
Impact of new onset diabetes on pancreatic cancer outcomes26
Expression and clinical significance of ERBB4 in gastric cancer24
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments24
Prognostic and safety analysis of capecitabine monotherapy versus CapeOx (capecitabine plus oxaliplatin) in elderly patients with high-risk stage II and stage III MRD-negative colorectal cancer23
Prognostic nomogram for T3–T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis23
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study23
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions22
Erratum: Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK21
Trends of mortality among patients with malignant neoplasms of digestive system in the United States from 2007 to 202121
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i20
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma20
Clinical model for predicting overall survival outcomes in individuals with hepatocellular carcinoma: a retrospective cohort analysis19
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment19
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database19
Rectal tumor fragmentation as a response pattern following chemoradiation18
Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer18
Prediction of early recurrence in patients with colorectal liver metastases17
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study17
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor17
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor16
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer16
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients16
What is the significance of mismatch repair deficiency in stage IV colon cancer?16
Influence of pre-operative sarcopenia on post-operative hepatic steatosis after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma16
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer16
A real-world study of oxaliplatin-induced hypersensitivity in colorectal cancer treatment based on the pharmacovigilance system in China: a cohort study15
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers15
Path towards personalized care of hepatocellular carcinoma: a nomogram for survival prediction15
Study on ensemble model with weight allocation based on improved dung beetle optimization algorithm for screening colorectal cancer using laboratory test indicators14
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?14
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study14
Clinical application of indocyanine green fluorescence imaging technology in laparoscopic rectal cancer surgery14
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage14
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma14
Clinical significance of transjugular intrahepatic portosystemic shunting for hepatocellular carcinoma complicated with portal hypertension14
LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma13
Regorafenib in refractory gastric cancer: modest median, meaningful milestone13
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol13
Targeting AKR1C1 overcomes lenvatinib resistance in hepatocellular carcinoma through the STAT3-ABC transporters pathway13
Private equity acquisitions of hospitals and the changing landscape of care for patients with gastrointestinal cancer13
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients13
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes13
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospecti13
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer13
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank13
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database12
Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report12
Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus12
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?12
Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study12
ΔSII-based nomogram for prognosis prediction after radical resection for hepatocellular carcinoma12
KCNC3 as a prognostic indicator and a predictive marker for immunotherapy in colorectal cancer12
The value of lipid metabolism-related genes in pancreatic cancer immunotherapy and drug prediction12
A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report11
A bioinformatics analysis of potential cellular communication networks in non-alcoholic steatohepatitis and colorectal adenoma using scRNA-seq and bulk-seq11
The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review11
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM311
Risk of de novo esophageal cancer in liver transplant recipients: systematic review and meta-analysis11
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?11
Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study11
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis11
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model11
A comparison of two methods of lymph node dissection along the left recurrent laryngeal nerve in McKeown minimally invasive esophagectomy11
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responses11
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment11
The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery10
Gastric and colorectal cancer incidence attributable to dietary factors in Korea10
Increasing colorectal cancer screening uptake—time to consider a more holistic socio-ecological approach10
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab10
Indeterminate nodule-like arterial phase hyperenhancement in the liver on CT: differentiation of hepatocellular carcinomas from vascular pseudolesions using a CT radiomics approach10
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II–III colorectal cancer10
Mismatch repair deficiency confers worse survival in stage IV colon cancer10
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report10
Peripheral regulatory T cells trajectory predicts progression-free survival in hepatocellular carcinoma patients during on-demand transarterial chemoembolization using joint model: a prospective study10
Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression10
Duodenal neuroendocrine tumors: how safe is endoscopic resection?10
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report9
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis9
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection9
PANoptosis-associated genes exhibit significant potential in the diagnosis of hepatocellular carcinoma9
IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma9
Anlotinib and penpulimab in advanced hepatocellular carcinoma: a new contender emerges9
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report9
Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer9
Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma9
Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer9
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome9
Diagnostic value of endoscopic ultrasound versus indocyanine green fluorescence imaging for sentinel and lymph node metastasis in patients with colorectal cancer9
Comparable survival outcome with anti-EGFR therapy in any treatment line in left-sided metastatic colorectal cancer9
Andrographolide potentiates anti-tumor immunity in colorectal cancer (CRC) by targeting voltage-dependent anion channel (VDAC) and activating the cGAS-STING axis9
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical study9
A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation9
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?9
Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: a novel predictive model9
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study9
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomiz9
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER datab8
Rare germline chromosome 1 duplication identified in young male with colon cancer: a case report investigating causality8
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective st8
Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms8
Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study8
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma8
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study8
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis8
Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway8
Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellu8
Impact of prolonged surgical waiting time on cancer-specific mortality in stage I–II pancreatic ductal adenocarcinoma patients who received radical resection8
Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report8
High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study8
Clinicopathological characteristics and prognosis of patients with mucinous adenocarcinoma originating from the left colon, right colon, or rectum: a nationwide retrospective study in China8
Development and validation of a LASSO-based nomogram for predicting anastomotic leakage in elderly patients after laparoscopic gastrectomy8
Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis8
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study8
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis8
Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retrospective cohort study8
Unexpected plasmablastic lymphoma in a young adult with unknown HIV infection: case report8
Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer8
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database8
Inflammatory pseudotumor-like extranodal classic Hodgkin lymphoma manifesting as bowel perforation in acquired immunodeficiency syndrome patient with disseminated leishmaniasis: a case report and appr8
Development and experimental validation of a senescence-related long non-coding RNA signature for prognostic prediction and immune microenvironment characterization in gastric cancer patients8
Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer8
PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-68
Identification of immunogenic cell death-related prognostic genes in gastric cancer8
Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma8
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition8
RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes7
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin7
Erratum: Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer7
The emerging role of intra-tumoral bacteria7
Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p7
Integrated bioinformatic and machine learning analysis identifies MCM7 and ADAM17 as potential biomarkers for early stage gastric cancer7
Glutaryl-CoA dehydrogenase: a key biomarker linking lysine degradation to hepatocellular carcinoma metastasis and prognosis via NF-KB signaling pathway7
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin7
Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma7
The molecular sub-type and the development and validation of a prognosis prediction model based on endocytosis-related genes for hepatocellular carcinoma7
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?7
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study7
Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma7
Erratum to Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo7
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study7
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis7
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation7
Radiofrequency ablation has similar short-term effects but significantly lowers the long-term effect compared with routine resection in the treatment of small hepatocellular carcinoma7
Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region7
Identification of prognostic biomarkers in colorectal cancer through multi-omics profiling of programmed cell death pathways7
Model construction and risk analysis of the lncRNA genes associated with the prognosis of esophageal adenocarcinoma with immune infiltration7
Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis7
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway7
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis7
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis7
A prognostic nomogram based on desmoplastic reaction/tumor deposit modified lymph node staging in colorectal cancer7
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?7
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer7
Recent advancements in systemic therapy for biliary tract cancers: a literature review7
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology7
The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis7
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor7
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis6
Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma6
Risk factors for exclusive lung metastasis in colorectal cancer: a comprehensive narrative review6
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis6
Current management of gastric adenocarcinoma: a narrative review6
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression6
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort6
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels6
Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital6
Primary gastric squamous cell carcinoma in a young adult with immunotherapy complications: a case report6
Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings6
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram6
ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer6
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway6
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction6
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO26
Impact of occlusal support on postoperative complications in patients with colorectal cancer resections6
The role of TMSB15A in gastric cancer progression and its prognostic significance6
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature6
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients6
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma6
Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis6
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study6
Molecular subtyping and prognostic model construction based on endosome-related genes in colorectal cancer6
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma6
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer6
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells6
Camrelizumab plus sorafenib or apatinib achieved long-term survival in a patient with hepatocellular carcinoma and an Eastern Cooperative Oncology Group performance status of 3: a case report5
Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma5
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancer5
The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma5
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment5
Development and validation of a nomogram based on neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio for predicting recurrence of colorectal adenoma5
Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma5
Outcomes in octogenarians following elective colorectal cancer surgery5
Genomic profiles and their associations with microsatellite instability status, tumor mutational burden, and programmed death ligand 1 expression in Chinese patients with colorectal cancer5
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy5
Toosendanin induces ferroptosis in gastrointestinal stromal tumor cells through the regulation of the NCOA4 ferritinophagy pathway: implications for tumor proliferation, migration, and invasion5
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?5
Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplan5
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy5
Association between the systemic immune inflammation index and recurrence or metastasis after interventional therapy in patients with primary liver cancer- a retrospective cohort study5
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review5
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing5
SPP1 promotes tumor progression in esophageal carcinoma by activating focal adhesion pathway5
The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer5
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data5
The impact of ulinastatin on postoperative clinical outcomes in patients with gastric cancer: a retrospective cohort analysis5
Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-la5
Promotion of perineural invasion of cholangiocarcinoma by Schwann cells via nerve growth factor5
Is radix ligation of the inferior mesenteric artery effective in Japanese-Style D3 radical lymph node dissection for sigmoid colon and rectal cancer surgery?—a single-center retrospective analysis sin5
A surgical nursing perspective analysis of glucose variability in BCLC stage B–C hepatocellular carcinoma patients with and without T2D within 1 year of hepatectomy: a retrospective cohort study from 5
Poorer prognosis of early gastric cardia cancer compared to early gastric non-cardia cancer: evidence from SEER database analysis5
Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma5
Effects of magnetic resonance imaging (MRI)-detected extramural vascular invasion (mrEMVI) and tumor deposits (TDs) on distant metastasis and long-term survival after surgery for stage III rectal canc5
A narrative review of the evolving role of immunotherapy in the management of esophageal and gastric cancer5
Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report5
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case report5
Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis5
A case series of 10 patients undergone linear cutter/stapler guiding device-led overlapped esophagojejunostomy: a preliminary study5
Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer5
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report5
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer5
Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers5
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study5
Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study5
Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and i5
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line tre5
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report5
A machine learning clinic scoring system for hepatocellular carcinoma based on the Surveillance, Epidemiology, and End Results database5
Corticosteroid-dependent immune checkpoint inhibitor-induced enterocolitis treated with vedolizumab: a case report5
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therap5
Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells5
Predictive models of lymph node metastasis in patients with gastrointestinal stromal tumors based on machine learning algorithms: a SEER-based retrospective study5
Identification of 8-gene risk prediction signature associated with NOTCH1 in stomach adenocarcinoma based on bioinformatics analysis5
Long-term outcome of metachronous, multiple, early Epstein-Barr virus-associated gastric carcinoma: a case report5
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes5
Global burden of gastric cancer attributed to high-salt diets: spatiotemporal trends and socio-demographic inequalities from 1990 to 20215
Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report5
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study5
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study5
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two ph5
Identification of candidate biomarkers associated with gastric cancer prognosis based on an integrated bioinformatics analysis4
Advances in mitophagy research in hepatocellular carcinoma: mechanisms and therapeutic implications4
Neoadjuvant and adjuvant therapy in esophageal cancer4
Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database4
ZNF454-FSTL3 axis inhibits colorectal cancer progression by inhibiting HIF-1α-mediated glycolysis in hypoxia4
Cultural and social barriers to hope in gastrointestinal cancer patients4
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional trans4
0.087502956390381